The challenge of drug resistance in pancreatic ductal adenocarcinoma: a current overview

Pancreatic ductal adenocarcinoma (PDAC) has one of the highest mortality rates among all cancer types. Its delayed diagnosis precludes curative resection, thus most of the current therapies against PDAC are based on chemo- and radiotherapy. Unfortunately, these strategies are insufficient to improve...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Cancer Biol Med
Main Authors: Quiñonero, Francisco, Mesas, Cristina, Doello, Kevin, Cabeza, Laura, Perazzoli, Gloria, Jimenez-Luna, Cristina, Rama, Ana Rosa, Melguizo, Consolación, Prados, Jose
Formato: Artigo
Idioma:Inglês
Publicado em: Chinese Anti-Cancer Association 2019
Assuntos:
Review
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6936232/
https://ncbi.nlm.nih.gov/pubmed/31908888
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.20892/j.issn.2095-3941.2019.0252
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados